MIRA INFORM REPORT
|
Report Date : |
21.09.2011 |
IDENTIFICATION DETAILS
|
Name : |
CHANGZHOU QH PHARMACEUTICALS TECHNOLOGY CO.,
LTD. |
|
|
|
|
Registered Office : |
Floor 11 Tower B, Tianrun Tech Building,
Science And Education Garden, No. 801 Changwu Middle Road, Wujin District,
Changzhou Jiangsu Province 213163 Pr |
|
|
|
|
Country : |
China |
|
|
|
|
Date of Incorporation : |
21.04.2010 |
|
|
|
|
Com. Reg. No.: |
320483000269212 |
|
|
|
|
Legal Form : |
One-Person Limited Liability Company |
|
|
|
|
Line of Business : |
Selling
Deworming
Medicine, Veterinary Medicine |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
USD 50,000 |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment
Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2011
|
Country Name |
Previous Rating (31.12.2010) |
Current Rating (31.03.2011) |
|
China |
a2 |
a2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company name & address
changzhou qh pharmaceuticals technology co.,
ltd.
floor 11 tower b, tianrun
tech building, science and education garden, no. 801 changwu middle road, wujin
district, changzhou JIANGSU PROVINCE 213163 PR CHINA
TEL: 86 (0)
519-68851599/68851528
FAX: 86 (0)
519-86395885
EXECUTIVE SUMMARY
Date of Registration : april 21, 2010
REGISTRATION NO. : 320483000269212
LEGAL FORM : One-person Limited Liability Company
REGISTERED CAPITAL :
cny 10,000,000
staff : 20
BUSINESS CATEGORY :
trading
Revenue : N/A
EQUITIES : N/A
WEBSITE : N/A
E-MAIL :
N/A
PAYMENT : AVERAGE
Recommended Credit Limit: UP TO USD
50,000
MARKET CONDITION : average
FINANCIAL CONDITION :
n/a
OPERATIONAL TREND :
ORDINARY
GENERAL REPUTATION : AVERAGE
EXCHANGE RATE : CNY 6.38 = USD 1
Adopted abbreviations
(as follows)
SC - Subject Company
(the company inquired by you)
N/A – Not available
CNY – China Yuan Ren
Min Bi
OPERATIONAL TREND & GENERAL
REPUTATION
This section aims at indicating the relative positions of SC in respect
of its operational trend & general reputation
Operational Trend:- General
Reputation:-
Upward Excellent
Steady Good
Fairly Steady Fairly
Good
Ordinary Average
Fair Fair
Stagnant Detrimental
Downward Not
known
Not known Not yet be
determined
Not yet be determined
LEGAL STATUS & HISTORY
SC was
established as a one-person limited liability company of PRC
with State Administration of Industry & Commerce (SAIC) under registration
No.: 320483000269212 on April 21, 2010.
SC’s Organization Code Certificate
No.: 55460428-7
SC’s registered capital: cny 10,000,000
SC’s paid-in capital: cny 10,000,000
No significant changes of SC have
been noted in SAIC since its incorporation.
Current Co search indicates SC’s shareholders & chief
executives are as follows:-
|
Name of Shareholder (s) |
% of Shareholding |
|
Changzhou Yabang-QH Pharmachem
Co., Ltd. |
100 |
SC’s Chief Executives:-
|
Position |
Name |
|
Legal Representative, Chairman,
and General Manager |
Liu Xiangyi |
|
Supervisor |
Jiang Guoyuan |
RECENT DEVELOPMENT
No recent development was found during our checks at present.
SHAREHOLDER CHART &
BACKGROUND
Name %
of Shareholding
Changzhou Yabang-QH Pharmachem
Co., Ltd. 100
==================================
Date of Registration: March 4, 2004
Registration No.: 320400400012708
Legal Form: Chinese-Foreign Equity Joint Venture Enterprise
Registered Capital: USD
1,280,000
Shareholder (s) (% of Shareholding) of Changzhou Yabang-QH Pharmachem Co., Ltd.
Quality Horizons, LLC (U.S.A.) (25%)
Changzhou Yabang Veterinary Co., Ltd. (75%)
***
Changzhou Yabang-QH Pharmachem Co., Ltd. (shortly called as
yabang-qh) is a sino-us joint venture professionally specialized in R&D,
manufacturing, sales and marketing of anthelmintic products. The company
currently owns two manufacturing factories, i.e. Changzhou Yabang Veterinary
Co., Ltd. located in the south suburb of Changzhou city, Changzhou Yabang-QH
Pharmachem Co., Ltd. located in the "pharmaceutical industrial base"
in Changzhou xinbei district (the sate spark program).
The company already obtained ISO9001
Certificate issued by Lloyd's Register Quality Assurance UK and Chinese GMP
Certificate. We also obtained the authentication on ISO14001 Environmental
Protection Management System and OSHAS18001 EHS System. The company was awarded
a lot of honors, such as "Hi-tech Enterprise in Jiangsu Province",
"The Top Fifty Veterinary Enterprises in China", "Advanced Clean
Production Enterprise" and "Enterprise with Great Science &
Technology Progress".
Web: www.yabangpharm.com
Address: No. 18, Jinlong Road, Chunjiang
Town, Xinbei District, Changzhou, Jiangsu Province, 213127 PR China
Tel: 86 (0) 519-68851566/68851528
Fax: 86 (0) 519-68851555
MANAGEMENT
Liu Xiangyi, Legal Representative, Chairman and General Manager
---------------------------------------------------------------------------------------------------
Ø
Gender: F
Ø
Age: 45
Ø
ID#
320421196609271923
Ø
Qualification:
University
Ø
Working
experience (s):
From 2010 to present, working in SC as legal representative,
chairman and general manager
Also working
in Changzhou Yabang-QH Pharmachem Co., Ltd.,
Lianyungang Yabang Pharmachem Co., Ltd. and Changzhou Yabang Veterinary
Co., Ltd. as legal representative
Jiang Guoyuan, Supervisor
-----------------------------------------------
Ø
Gender: M
Ø
Age: 68
Ø
ID# 320421194312211832
BUSINESS OPERATION
SC started its normal operation at the end of 2010.
SC’s registered business scope includes R&D of chemical raw materials and pharmaceutical intermediates,
chemical products, proprietary Chinese medicines, chemical drugs, antibiotics,
biochemical drugs, topical insecticide, disinfectant for animals, and related
technology consulting, technology transfer, technology services, selling
chemical raw materials and chemical products, chemical machinery,
pharmaceutical equipment, laboratory equipment, operating and acting as an
agent of importing and exporting various kinds of commodities and technology,
excluding the goods forbidden by the government.
SC is
mainly engaged in selling deworming medicine, veterinary medicine.
SC’s
products mainly include: benzimidazoles, diphenylsulfides, imidazothiazoles,
salicylanilides, etc.
SC sources its materials 100% from domestic
market, mainly Changzhou. SC sells 100% of its products to overseas market,
mainly USA, Europe, Middle East and Southeast Asia.
The
buying terms of SC include Check, T/T and Credit of 30-60 days. The payment
terms of SC include L/C and Credit of 30-60 days.
*Major Supplier:
=============
Changzhou Yabang-QH Pharmachem Co., Ltd.
Staff & Office:
--------------------------
SC is
known to have approx. 20
staff at present.
SC rents an area
as its operating office, but the detailed information is unknown.
RELATED COMPANY
u Changzhou Yabang Veterinary Co.,
Ltd.
u
Lianyungang Yabang Pharmachem Co., Ltd.
Etc.
PAYMENT
Overall payment appraisal:
( ) Excellent ( ) Good (X) Average ( ) Fair ( ) Poor ( ) Not yet be determined
The appraisal serves as a reference to reveal SC's payments habits and
ability to pay. It is based on the 3
weighed factors: Trade payment experience (through current enquiry with SC's
suppliers), our delinquent payment and our debt collection record concerning
SC.
Trade payment experience: SC’s suppliers
declined to make any comments.
Delinquent payment record: None in our
database.
Debt collection record: No overdue amount
owed by SC was placed to us for collection within the last 6 years.
BANKING
The bank information
of SC is not filed in SAIC.
FINANCIALS
SC started its normal operation at the end of 2010, so its financials
are not filed in local SAIC at present.
CONCLUSIONS
SC is considered medium-sized in its line with a short business history.
A credit line up to USD 50,000
would appear to be within SC’s capacities.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.48.22 |
|
UK Pound |
1 |
Rs.75.63 |
|
Euro |
1 |
Rs.65.65 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial condition
(40%) Ownership background
(20%) Payment record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.